loader
Please Wait
Applying Filters...

Quotient Sciences Quotient Sciences

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Approved Drug Products containing 21717 listed in the FDA Orange Book. Original Data : FDA Website

    Client Virtual Booth
    Menu

    Taro Pharmaceutical Industries

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 TARO (1)

    filter

    01 CREAM;TOPICAL (1)

    filter

    01 DISCN (1)

    filter

    01 PLIAGLIS (1)

    filter

    01 Yes (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    LIDOCAINE; TETRACAINE

    PDF Supplier PDF
    URL Supplier Web Content
    CREAM; TOPICAL
    7%;7%
    2006-06-29
    21717
    PLIAGLIS
    DISCN
    Yes
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for FDA Orange Book APPLICATION 21717

    Looking for FDA Orange Book APPLICATION 21717 1

    19

    Taro Pharmaceutical Industries, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    One of their notable products is LIDOCAINE; TETRACAINE, with a corresponding application number 21717.

    Regulatory Information DISCN

    With a dosage strength 7%;7%

    Dosage Form Route CREAM; TOPICAL

    Reference Listed Drug Yes

    Approved since 2006-06-29

    Post Enquiry
    POST ENQUIRY